GlobalData
GlobalData

Business Fundamentals

Influencers opine Google Chrome acquisition could potentially be advantageous for Perplexity, reveals GlobalData

Perplexity captured the spotlight among influencers in the mid of August 2025, after making a bold $34.5 billion unsolicited offer to acquire Google Chrome amid the ongoing antitrust scrutiny facing Google. The offer has ignited discussions about the potential ramifications for competition and innovation in the technology industry. Influencers noted that the bid could be […]
Read more

South Korea emerges as pharma licensing hub with 113% growth in total deal value in 2025 YTD, reveals GlobalData

South Korea’s biopharmaceutical sector is experiencing a surge in innovator drug licensing agreements, with a total deal value of $7.86 billion year-to-date (YTD) in 2025, marking a 113% increase from 2024, according to GlobalData, a leading data and analytics company. Ophelia Chan, Senior Business Fundamentals Analyst at GlobalData, comments: “The momentum is largely attributed to […]
Read more

Global IPO market proceeds YoY climb 9.5% in first seven months of 2025, reveals GlobalData

The global IPO market displayed remarkable resilience in the first seven months of 2025, with proceeds rising 9.5% year-on-year (YoY) to $56.8 billion despite persistent market volatility and policy uncertainty. Strong investor appetite, especially in Asia-Pacific, reflects a strategic shift toward high-value listings, underpinned by favorable macroeconomic fundamentals and a recalibration of corporate capital-raising strategies […]
Read more

Influencers hail OpenAI’s new models as breakthrough development for AI accessibility and innovation, reveals GlobalData

OpenAI Inc. has become a trending company among influencers in the first week of August 2025 due to the release of two significant open-weight models, GPT-OSS-120B and GPT-OSS-20B, which can run locally on consumer hardware. This move marks a pivotal shift from OpenAI’s previous closed API business model, allowing developers and researchers to access advanced […]
Read more

US tariffs prompt GlobalData to revise India economic growth forecast down to 6.5% in July 2025

Following the news that the US will impose 25% tariffs on all Indian imports starting from 1 August 2025; Ramnivas Mundada, Director of Economic Research and Companies at GlobalData, a leading data and analytics company, offers his view: “These significant tariffs, coupled with penalties linked to India’s dealings with Russian energy and military supplies, pose […]
Read more

Hyundai’s Q2 2025 advertising campaigns showcase innovation, performance, and sustainability, reveals GlobalData

Hyundai’s YouTube advertising campaigns for Q2 2025 focus on promoting various models, including the IONIQ series, Palisade, and N Vision 74. The ads emphasize sustainability, performance, and community engagement, highlighting Hyundai’s commitment to eco-friendly technology and high-performance vehicles. This integrated approach not only showcases Hyundai’s automotive advancements but also aligns with evolving consumer expectations, reveals […]
Read more

Influencer sentiment soars as Tesla partners with Samsung for next-gen AI chip, reveals GlobalData

Tesla has emerged as a trending company among influencers on X, primarily due to its significant $16.5 billion contract with Samsung Electronics for the manufacturing of advanced semiconductors. This partnership marks a pivotal moment for both companies. For Tesla, it solidifies its position in the competitive electric vehicle (EV) and AI landscape, while for Samsung, […]
Read more

Unitree Robotics’ launch of affordable humanoid robot sparks excitement among influencers on X, reveals GlobalData

Unitree Robotics has recently emerged as a trending topic among influencers on social media, largely due to the launch of its new low-cost humanoid robot, the R1, priced at around $5,900. This pricing strategy has drawn comparisons to DJI’s early market tactics, where undercutting competitors helps establish a dominant position. Influencers on “X” have noted […]
Read more

Top 20 biopharmaceutical companies see 7.9% increase in aggregate revenue in 2024, reveals GlobalData

The biopharmaceutical industry had a positive year in 2024, with obesity drug developers continuing to witness success. Nearly all (19) of the top 20 players publicly traded global biopharmaceutical companies reported revenue growth in 2024, with an overall 7.9% year-on-year (YoY) increase in aggregate revenue to $880.4 billion, reveals GlobalData, a leading data analytics and […]
Read more
1 12 13 14 15 16 131